To the editor

Critical Reviews in Biochemistry and Molecular Biology

Volumn 44, Issue 2-3, 2009, Pages 64-

  Jentsch, Thomas J ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUBIPROSTONE;

CELL STRAIN HEK293; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL;

EID: 70350516821     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409230902814887     Document Type: Letter

References (5)

1. Jentsch TJ. 2008. CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol. 43:3-36.
2. Bao HF, Liu L, Self J, Duke BJ, Ueno R, and Eaton D. 2007. A synthetic prostone activates apical chloride channels in A6 epithelial cells. 2008. Am J Physiol Gastrointest Liver Physiol. 295:234-251.
3. Johanson JF, and Ueno R. 2007. Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efcacy and safety. Aliment Pharmacol Ter. 25:1351-1361.
4. Johanson JF, Morton D, Geenen J, and Ueno R. 2008. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 103(1):170-177
5. Amitiza [package insert]. 2008. Bethesda, MD: Sucampo Pharmaceuticals, Inc.